Boriskin YS - Search Results

1

Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol.

Leneva IA, Russell RJ, Boriskin YS, Hay AJ. Leneva IA, et al. Among authors: boriskin ys. Antiviral Res. 2009 Feb;81(2):132-40. doi: 10.1016/j.antiviral.2008.10.009. Epub 2008 Nov 24. Antiviral Res. 2009. PMID: 19028526

2

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection.

Boriskin YS, Pécheur EI, Polyak SJ. Boriskin YS, et al. Virol J. 2006 Jul 19;3:56. doi: 10.1186/1743-422X-3-56. Virol J. 2006. PMID: 16854226 Free PMC article.

3

Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.

Pécheur EI, Lavillette D, Alcaras F, Molle J, Boriskin YS, Roberts M, Cosset FL, Polyak SJ. Pécheur EI, et al. Among authors: boriskin ys. Biochemistry. 2007 May 22;46(20):6050-9. doi: 10.1021/bi700181j. Epub 2007 Apr 25. Biochemistry. 2007. PMID: 17455911 Free PMC article.

4

Arbidol: a broad-spectrum antiviral compound that blocks viral fusion.

Boriskin YS, Leneva IA, Pécheur EI, Polyak SJ. Boriskin YS, et al. Curr Med Chem. 2008;15(10):997-1005. doi: 10.2174/092986708784049658. Curr Med Chem. 2008. PMID: 18393857 Review.

5

Association of cytomegalovirus infection with post-transplantation cardiac rejection as studied using the polymerase chain reaction.

Fernando S, Booth J, Boriskin Y, Butcher P, Carrington D, Steel H, Tryhorn Y, Corbishley C, Keeling P, Murday A, et al. Fernando S, et al. J Med Virol. 1994 Apr;42(4):396-404. doi: 10.1002/jmv.1890420412. J Med Virol. 1994. PMID: 8046430

6

Myxoviruses do not induce non-specific alterations in membrane permeability early on in infection.

Foster KA, Micklem KJ, Agnarsdottir G, Lancashire CL, Bogomolova NN, Boriskin YS, Pasternak CA. Foster KA, et al. Among authors: boriskin ys. Arch Virol. 1983;77(2-4):139-53. doi: 10.1007/BF01309263. Arch Virol. 1983. PMID: 6314933

7

Genetic evidence for variant selection in the course of dilute passaging of mumps vaccine virus.

Boriskin YS, Yamada A, Kaptsova TI, Skvortsova OI, Sinitsyna OA, Takeuchi K, Tanabayashi K, Sugiura A. Boriskin YS, et al. Res Virol. 1992 Jul-Aug;143(4):279-83. doi: 10.1016/s0923-2516(06)80116-0. Res Virol. 1992. PMID: 1410827

8

Comparative study of rabies virus persistence in human and hamster cell lines.

Andzhaparidze OG, Bogomolova NN, Boriskin YS, Bektemirova MS, Drynov ID. Andzhaparidze OG, et al. Among authors: boriskin ys. J Virol. 1981 Jan;37(1):1-6. doi: 10.1128/JVI.37.1.1-6.1981. J Virol. 1981. PMID: 7218421 Free PMC article.

9

DNA microarrays for virus detection in cases of central nervous system infection.

Boriskin YS, Rice PS, Stabler RA, Hinds J, Al-Ghusein H, Vass K, Butcher PD. Boriskin YS, et al. J Clin Microbiol. 2004 Dec;42(12):5811-8. doi: 10.1128/JCM.42.12.5811-5818.2004. J Clin Microbiol. 2004. PMID: 15583316 Free PMC article.

10

Molecular epidemiology and significance of a cluster of cases of CMV infection occurring on a special care baby unit.

Aitken C, Booth J, Booth M, Boriskin Y, Testard H, Kempley S, Breuer J. Aitken C, et al. J Hosp Infect. 1996 Nov;34(3):183-9. doi: 10.1016/s0195-6701(96)90064-x. J Hosp Infect. 1996. PMID: 8923272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results